Hopp til hovedinnhold

Svettekjertelbetennelse (hidradenitis suppurativa)

Svettekjertelbetennelse (hidradenitis suppurativa) er en betennelse i hårsekkene i områder på kroppen med svettekjertler, oftest i armhuler eller lyske.

Sist revidert:

QR
Del pasientinformasjon

Den ligger åpent tilgjengelig på NHI.no sammen annen relevant informasjon

https://nhi.no/sykdommer/infeksjoner/bakteriesykdommer/svettekjertelbetennelse-hidradenitis-suppurativa/ 

Hva er svettekjertelbetennelse?

Årsaker

Diagnosen

Behandling

Forebygging

Vil du vite mer?

Kilder

Referanser

Dette dokumentet er basert på det profesjonelle dokumentet Hidradenitis suppurativa. Referanselisten for dette dokumentet vises nedenfor.

  1. Helsedirektoratet (2021). Nasjonal faglig retningslinje for antibiotika i primærhelsetjenesten nettdokument. Oslo: Helsedirektoratet (sist faglig oppdatert 16. november 2021, lest jan 2022).
  2. Collier F, Smith RC, Morton CA. Diagnosis and management of hidradenitis suppurativa. British Medical Journal 2013; 346: f2121. doi:http://dx.doi.org/10.1136/bmj.f2121
  3. Ingram JR, Woo PN, Chua SL, Ormerod AD, Desai N, Kai AC, Hood K, Burton T, Kerdel F, Garner SE, Piguet V. Interventions for hidradenitis suppurativa. Cochrane Database of Systematic Reviews 2015, Issue 10. Art. No.: CD010081. DOI: 10.1002/14651858.CD010081.pub2. The Cochrane Library 
  4. Jfri A, Nassim D, O'Brien E, et al. Prevalence of Hidradenitis Suppurativa A Systematic Review and Meta-regression Analysis. JAMA Dermatol 2021. pmid:34037678 PubMed 
  5. Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009 Apr. 60(4):539-61.
  6. Kelly G et al. Vitamin D status in hidradenitis suppurativa. Br J Dermatol 2014 doi: 10.1111/bjd.12900 DOI 
  7. Crowley JJ, Mekkes JR, Zouboulis CC, et al. Association of Hidradenitis Suppurativa Disease Severity with Increased Risk for Systemic Comorbidities. Br J Dermatol. 2014; 171: 1561-5. PMID: 24842009 PubMed 
  8. Wipperman J, Bragg DA, Litzner B. Hidradenitis Suppurativa: Rapid Evidence Review. Am Fam Physician. 2019 Nov 1;100(9):562-569. PMID: 31674740.
  9. Ravi S, Miles JA, Steele C, et al. Patient Impressions and Outcomes After Clinic-Based Hidradenitis Suppurativa Surgery. JAMA Dermatol 2022. pmid:34985494 PubMed 
  10. Ingram JR. Hidradenitis suppurativa: Management. UpToDate last updated Jan 13, 2022. UpToDate 
  11. Jemec GB. Clinical practice. Hidradenitis suppurativa. N Engl J Med. 2012 Jan 12. 366(2):158-64.
  12. Danielsen K, Tzellos T, Antonsen OH, Pritzier EC. Veileder for behandling av hidradenitis suppurativa i Norge. Norsk forening for dermatologi og venerologi. 2019. www.legeforeningen.no 
  13. Kimball AB, Okun MM, Williams DA, et al. Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa. N Engl J Med. 2016; 375(5):422-34. doi: 10.1056/NEJMoa1504370.
  14. Bechara FG, Podda M, Prens EP, et al. Efficacy and Safety of Adalimumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa The SHARPS Randomized Clinical Trial. JAMA Surg 2021; 156: 1001-9. pmid:34406349 PubMed 
  15. Zouboulis CC, Bechara FG, Dickinson-Blok JL, et al. Hidradenitis suppurativa/acne inversa: A practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group. J Eur Acad Dermatol Venereol 2018. pmid:30176066 PubMed 
  16. Soria A, Canoui-Poitrine F. Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patient’s outcome assessment. Dermatology 2009; 218: 134-5. DOI:10.1159/000182261. DOI 
  17. Boer J, Nazary M. Long term effects of acitretin therapy for hidradenitis suppurativa. Br J Dermatol 2011; 164: 170-5. DOI:10.1111/j.1365-2133.2010.10071.x DOI 
  18. Nikolakis G, Kyrgidis A, Zouboulis CC. Is There a Role for Antiandrogen Therapy for Hidradenitis Suppurativa? A Systematic Review of Published Data. Am J Clin Dermatol. 2019 Aug;20(4):503-513. PMID: 31073704. PubMed 
  19. Dhaliwal S, Nguyen M, Vaughn AR et al. Effects of Zinc Supplementation on Inflammatory Skin Diseases: A Systematic Review of the Clinical Evidence. Am J Clin Dermatol. 2020 Feb;21(1):21-39. PMID: 31745908.
  20. Brocard A, Knol AC. Hidradenitis suppurativa and zinc: a new therapeutic approach. Dermatology 2007; 214: 325-7. doi:10.1159/000100883 DOI 
  21. Nordic Nutrition Recommendations 2012
  22. van der Zee HH, Prens EP, Boer J. Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. J Am Acad Dermatol 2010; 63: 475. pmid:20708472 PubMed 
  23. Madan V, Hindle E, Hussain W, August PJ. Outcomes of treatment of nine cases of recalcitrant severe hidradenitis suppurativa with carbon dioxide laser. Br J Dermatol. 2008 Dec. 159(6):1309-14.
  24. Egeberg A, Gislason GH, Hansen PR. Risk of major adverse cardiovascular events and all-cause mortality in patients with hidradenitis suppurativa. JAMA Dermatol 2016. doi: 10.1001/jamadermatol.2015.6264 DOI